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Structural decoding of netrin-4 reveals a regulatory
function towards mature basement membranes
Raphael Reuten1,2,*,w, Trushar R. Patel3,4,*, Matthew McDougall5,*, Nicolas Rama6, Denise Nikodemus1,2,
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Wilhelm Bloch18, Hauke Clausen-Schaumann7,9, Ernst Poschl11, Peter D. Yurchenco13, Martin Ehrbar10,
Patrick Mehlen6,**, Jo¨rg Stetefeld5,** & Manuel Koch1,2,**
Netrins, a family of laminin-related molecules, have been proposed to act as guidance cues
either during nervous system development or the establishment of the vascular system. This
was clearly demonstrated for netrin-1 via its interaction with the receptors DCC and UNC5s.
However, mainly based on shared homologies with netrin-1, netrin-4 was also proposed to
play a role in neuronal outgrowth and developmental/pathological angiogenesis via interac-
tions with netrin-1 receptors. Here, we present the high-resolution structure of netrin-4,
which shows unique features in comparison with netrin-1, and show that it does not bind
directly to any of the known netrin-1 receptors. We show that netrin-4 disrupts laminin
networks and basement membranes (BMs) through high-afﬁnity binding to the laminin g1
chain. We hypothesize that this laminin-related function is essential for the previously
described effects on axon growth promotion and angiogenesis. Our study unveils netrin-4 as
a non-enzymatic extracellular matrix protein actively disrupting pre-existing BMs.
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T
he netrin protein family is comprised of six members, the
secreted netrins -1, -3, -4, -5 and the glycosylpho-
sphatidylinositol (GPI)-anchored netrins-G1 and -G2 in
mammals and exhibit homology to the N-terminal domains
(LN-LEa1-3) of laminin short arms1–8. Secreted netrins-1,-3 and
-5 are homologous to the laminin g1 chain, whereas netrin-4
(Net4) shares a higher identity to the b1 chain (50%). Netrin-1
(Net1) has been studied in detail and the name netrin, from
‘the one who guides’ in Sanskrit was given to this family of
laminin-related molecules because of Net1 activity2. Net1 one of
the ﬁrst studied secreted guidance factors, plays a major role in
promoting both axon outgrowth and axon orientation during
nervous system development9, as well as in developmental
angiogenesis. Given the structural and functional similarities
between the axon growth cone and the endothelial tip cell10 in
both systems netrin-1 function is due to its ability to engage the
receptors DCC and UNC5H (that is, UNC5A, UNC5B, UNC5C
and UNC5D)11–13 and possibly other receptors such as neogenin,
A2b, some integrins or DSCAM14–17. Because of the similarity of
Net1 and Net4, the majority of studies of Net4 have been focused
on describing functions of Net4 based on an assumed interaction
of Net4 with DCC or UNC5 and with a guidance function. Works
include reported neuronal guidance function3 and pro- as well as
anti-angiogenic activity18–20. The most prominent in vitro
function of Net4 is the inhibition of endothelial tube-like
structure formation when Net4 is applied to endothelial cells
seeded on Matrigel20. In addition, different cancer cells
transfected with Net4 form less-vascularized solid tumours18,19.
In most cases, it was speculated that Net4 acts mainly via binding
to Net1 receptors of the DCC/neogenin family and UNC5 family
members19–21. Recently, the binding epitopes of Net1 for DCC,
neogenin and UNC5B were identiﬁed22–24; however, the
proposed binding sites are not conserved within Net4. Of
interest, even though these studies have received little attention,
it was proposed that Net4 binds to the laminin g1 chain25,26.
Together with the fact that most in vitro effects shown with Net4
were obtained from culture in reconstituted matrix such as
Matrigel mainly composed of laminin 111, we hypothesized
that the Net4 by interacting with laminin g1 could impact
on the Matrigel in vitro and on the basement membrane (BM)
in vivo.
The BM is a specialized extracellular matrix mainly composed
of laminin and collagen IV polymers27 as well as a number of
additional proteins. This matrix provides a substrate for cell
attachment, serves as a barrier, and is a source of growth factors.
As an example, in the vasculature the BM is located at the basal
side of the endothelium. The vascular BM (vBM) assembles from
proteins produced by endothelial as well as perivascular cells
(PVCs)28. Continuous formation of the vBM along the
endothelium stabilizes newly formed vessels and promotes their
maturation28,29. Ablation of the BM core component collagen IV
leads to vascular defects, haemorrhages and embryonic lethality
at E10.5 in mouse30. However, these mice still contain
BM-like sheets assembled through laminins30. Although, the
ultrastructural morphology of BMs is similar between different
tissues, variations in protein composition are seen depending on
location and during development. Laminins 411 and 511 are the
predominant isoforms in the vBM formed by the b1, g1 and
either the a4 or the a5 chain. Laminin 411 is expressed in the
vasculature during early developmental stages and deﬁciency of
the laminin a4 chain leads to a vascular phenotype with transient
perinatal hemorrhages31. In contrast, laminin 511 is found in the
vBM of adult mice32. Laminin 511, in contrast with laminin 411,
contains laminin N-terminal globular (LN) domains on each of
its short arms allowing its assembly into a network that is bound
to endothelial cell surfaces through integrins, sulfatides and
a-dystroglycan. Following laminin assembly at cell surfaces,
collagen IV is integrated into the BM33–35.
Here, we present the high-resolution structure of Net4 showing
unique features that are absent in Net1 as well as in the
N-terminal laminin structures and identify the binding epitopes
required for a stable Net4/laminin g1 heterodimeric complex. On
the basis of this high-resolution structure, we designed Net4
mutants that negatively impede interaction with laminin g1,
possibly explaining previously observed ex vivo effects, on axon
outgrowth modulation, and angiogenic activity. Our data also
elucidate a mechanism by which Net4 inﬂuence the laminin
network and play a vital role in angiogenesis. We also propose
that the anti-angiogenic property of Net4 in vivo is directly
related to its impact on BM rearrangement.
Results
Net4 has unique structural features absent in other netrins. In
order to establish the structure-function relationship of Net4, we
solved the crystal structure of Net4 lacking the C-terminal
domain (Net4-DC) at 3.1 Å (Table 1), revealing a head to stalk
arrangement of 175Å in length (Fig. 1a,b). The globular shaped
N-terminal domain (LN) forms the head and the three and a half
rod-like consecutive LE domains make up the stalk (Fig. 1a,b).
The LN domain forms a b-sandwich jelly-roll motif with a front
face composed of sheet S5-S2-S7 and a dorsal face composed of
sheet S4-S3-S6-S1 (Table 1). The topology of this domain is
similar to the N-terminal domain of Net1 (refs 22–24); however,
the closest structural homologue is the short arm of laminin b1
(Supplementary Fig. 1a,b). Signiﬁcant structural features make
this structure unique among netrins. The LN domain is stabilized
by a complex pattern of disulﬁde bridges composed of 12 cysteine
residues (Fig. 1a,b). Two disulﬁde bridges between cysteine resi-
dues 72–236 and 191–234, absent in any current netrin or
laminin structure, hold the S6-S7 loop in place (Fig. 1b). This
loop is adjacent to loop rS1-rS2, which contains the conserved
Ser65 (Supplementary Fig. 2a). Interestingly, in laminin b1
(Lmb1), the replacement of this conserved serine by an arginine
allows for the formation of a binary complex between b1 and g1
laminins; however, the ternary complex formation with the
laminin a chain is abolished. Furthermore, there is clear electron
density for glycan additions at three asparagine-linked glycosy-
lation sites, Asn56, Asn163, and Asn353 (Supplementary Fig. 2b).
The ﬁrst two glycan chains are located at opposite edges of the LN
domain, while Asn353 is located at the loop b helix of LE2 and
extends towards the bottom of the LN domain (Fig. 1a,b).
Remarkably, Net4 is the ﬁrst member of the netrin family with no
N-linked glycan attachment at the dorsal face of the N-terminal
domain. Net4-DC has a total accessible surface area of
B28,000Å2 and reveals extensive inter-domain contacts between
the LN domain and subdomain LE1 (Fig. 1a,b). Loop b of the LE1
domain has a large buried surface area of B1,700Å2 with the
lateral edge of the LN domain (Fig. 1c). In addition, loop d of the
LE1 domain is ﬂanked by the Asn353-linked glycan attachment
and trapped between the N-terminal segment and the basal helix
of the LN domain (Fig. 1d). Together, these extensive contact
areas may limit the rotational freedom of the LN domain in
comparison with other netrins. Each of the individual
LE-subdomains adopts the classical LE-fold36 consisting of
irregular coil segments and forms a linear extended structure.
Net4 does not interact with Net1 receptors. As the DCC and
UNC5B-binding epitopes of Net1 are absent in the Net4 struc-
ture22–24, we examined whether Net4 could interact with the
ectodomains of DCC, UNC5B, A, C, D and more generally A2b,
neogenin as well as DSCAM that have been previously reported
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Figure 1 | Overall structure of Net4. (a) Ribbon model of Net4-DC viewed in the ‘open face’ orientation. The domains LN (teal), LE1 (orange) LE2
(magenta) and LE3-31/2 (green) are coloured accordingly. N-linked glycans are drawn as red sticks, disulﬁde bridges are drawn as yellow sticks, and the
calcium ion as a red sphere. (b) Secondary structure diagrams. Disulﬁde connectivity in domains LN and LE are indicated by yellow dotted lines, visible
N-linked glycans by green stars with the Asn residues N56, N163 and N353 highlighted. b-strands are depicted as arrows and the a-helices as cylinders, each
labelled with the ﬁrst and last residue. The individual loop segments are shown in different colour codes. (c) Interface between domains LE1 and LN. The
KAPG motif is free in solution and not visible in the structure. (d) Secondary interface between domains LE1 and LN. The loop d segment between Cys307
and Cys329 of subdomain LE1 is in contact with the N-terminus and the loop S5-H3 of domain LN. (e) Complex of Net1 (marine; PDB 4OVE) and DCC
(orange; PDB 4URT) at site 1 with interacting residues shown at full opacity and the same complex with Net4 (green) replacing Net1. (f) Complex of Net1
(marine) and DCC (orange; PDB 4URT) at site 2 with interacting residues shown at full opacity and the same complex with Net4 (green) replacing Net.
(g) Complex of Net1 (marine) and neogenin (pink; PDB 4PLN) at site 1 with interacting residues shown at full opacity and the same complex with Net4
(green) replacing Net1. Similar to site 1 of the DCC-Net1 complex, F441 (red) of Net4 occludes Met959 of neogenin from the hydrophobic pocket. L456
(red) of Net4 again clashes with the binding partner. (h) Net1 (marine) in complex with neogenin (pink) at site 2. Note the difference in the surface charge
at the neogenin binding site (indicated by a box) of Net1 (left) and the corresponding site on Net4 (right).
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to interact with Net1, using solid-phase binding assays and Octet
technology. Structural analysis of Net4 and previously published
Net1 complex structures reveals incompatibility between the
binding residues of Net1 and equivalently positioned residues of
Net4 (Fig. 1e–h). For example, Phe441 of Net4 occludes the
conserved Met from the hydrophobic pocket in both DCC and
neogenin (Fig. 1e,g), and Leu458 of loop b in the terminal LE
domain of Net4 would preclude interaction with the netrin
receptor. The absence of the positively charged residues of Net1
(Arg348, Arg349, Arg351 and Arg372) necessary for a sulfate-
mediated interaction with DCC in Net4 would hinder interaction
between DCC and Net4 (Fig. 1f). The binding of neogenin to the
LN domain involves 10 residues of Net1, which are completely
non-conserved in Net4, as presented by the electrostatic surface
potential (Fig. 1h). The buried surface area of this interaction is
B680Å2, and covers a large portion of the LN domain of Net1.
None of the residues from Net1 that interact with neogenin are
conserved in Net4 (Fig. 1h).
While Net1 interacts in the nanomolar range with DCC and
UNC5B, Net4 does not show any interaction with any of the
proposed Net1 receptors including DCC/neogenin, UNC5 and
integrins (Fig. 2a and Supplementary Fig. 3). Sequence alignments
of netrin family proteins further highlight that almost all residues
involved in Net1 interaction with the canonical netrin receptors
are not conserved in Net4 (Supplementary Fig. 4). Together these
observations support the view that Net4 does not interact at least
directly with the known Net1 receptors, even though we can
discard that in some speciﬁc settings a protein complex may
include Net4 and Net1 receptors.
Net4 forms a high-afﬁnity complex with laminin c1. Although
full-length Net4 is reported to exist as a dimer3 and is therefore
believed to bridge two laminin heterotrimers, our crosslinking
experiments as well as hydrodynamic studies reveal that
full-length Net4 (Net4-FL) forms a high-afﬁnity complex
with laminin g1 (Lmg1) in a 1:1 molar ratio (Supplementary
Fig. 5a–e). The hydrodynamic radius (rH) from dynamic light
scattering (5.77±0.02 nm) and the sedimentation coefﬁcient
from analytical ultracentrifugation (AUC, 5.15±0.01 S) conﬁrm
unambiguously the existence of an equimolar heterodimeric
complex with a molecular mass of 116 kDa. The rotary shadowing
experiments reveal a central globular structure with two elongated
rods oriented in opposite directions, consistent with a LN
domain-mediated major binding interface with both elongated LE
subdomains oriented in an antiparallel fashion (Fig. 2c). Small
angle X-ray scattering (SAXS) studies of g1LN-LEa1-4 in
complex with full-length Net4 (Net4-FL) yield an extended
conformation with a maximum particle size (Dmax) of 19 nm
(Supplementary Fig. 5d and Supplementary Table 1). Rigid body
ﬁtting allows the reconstruction of the assembly of full-length
Net4 and laminin g1 (Net4-FL-g1LN-LEa1-4) in contact through
the LN domains, with the C-terminal domain of Net4 (domain C)
curling back over the LE domains. As presented in Fig. 2b, both
N-terminal b-sandwiches are oriented like the palms of two
hands with the open face sheets S5-S2-S7 (Net4) and S6-S3-S8
(laminin g1) in contact with each other (Fig. 2b and
Supplementary Movie 1). The models were validated extensively
by comparing experimentally determined hydrodynamic
properties with model derived hydrodynamic properties as
presented in the Supplementary Table 1. The comparison of
Net4-DC and Net4-FL binding to laminin g1 indicated equal
afﬁnities in the range of KD¼ 2 nM, validating the exclusion of
domain C of Net4 in complex formation (Fig. 2d). To decipher
individual amino acid residues responsible for Net4-laminin g1
interactions, we designed mutants based on the three-
dimensional structure of Net4 as well as the phylogenetic
conservation (Supplementary Fig. 1a,b). A structure-guided
deletion of the unique Net4 loop b (KAPGA) resulted
in a 25-fold reduction of KD from 2nM (Net4-DC) to
B50 nM (Net4-DCDKAPGA) (Supplementary Fig. 6a,b). Thus,
Net4-DCDKAPGA emphasizes the importance of the KAPGA loop
in complex formation and gives a rationale for the lower afﬁnity
of laminin b1 to laminin g1 (KD of 5 mM)33,35, as this loop is only
present in Net4. Moreover, we identiﬁed two residues (E195 and
R199) within the LN domain of Net4 involved in laminin g1
binding. Mutation of these two residues results in a decreased KD
from 2 to 66 nM (Supplementary Fig. 6c). In addition, mutation
of E195 as well as R199 together with deletion of loop b
(Net4-DCE195A,R199A,DKAPGA) completely abolishes binding in all
performed binding assays (Fig. 2d and Supplementary Fig. 6a,b).
Crosslinking experiments conﬁrm that full-length Net4 (Net4-FL)
exists as a monomer and dimer, because increasing crosslinker
concentration results in an increase in dimeric and multimeric
Net4-FL (Supplementary Fig. 5a). The rH of Net4-FL was
determined to be 5.76±0.02 nm which is very similar to that of
Net4-FL-g1LN-LEa1-4 (5.77±0.02 nm) and Net4-DC-g1LN-
LEa1-4 (5.40±0.10 nm) complexes but signiﬁcantly higher than
Net4-DC (4.60±0.20 nm), implying that full-length Net4
(Net4-FL) behaves as a mixture of monomer and dimer in
solution (Supplementary Fig. 5e and Supplementary Table 1).
The maximum particle size (Dmax) calculated from SAXS data for
Net4-FL is signiﬁcantly higher than the Dmax of Net4-DC, but
similar to both complexes (Supplementary Fig. 5e and
Supplementary Table 1). The AUC studies of Net4-FL provided
two peaks corresponding to a monomer and to a dimer for
Net4-FL, while Net4-DC (ref. 37) and complexes of Net4-FL and
Net4-DC with g1LN-LEa1-4 yield only a single peak
(Supplementary Fig. 5e). These experiments provide evidence
that full-length Net4 (Net4-FL) exists as a mixture of monomer
Table 1 | Data collection and reﬁnement statistics.
Net4-DC
Data collection
Space group C121
Cell dimensions
a, b, c (Å) 107.755, 74.049, 74.672
a,b,g () 90, 96.072, 90
Resolution (Å) 46.00-3.07 (3.12-3.07)*
No. reﬂections 39327 (1952)
Rmerge 0.194 (0.776)
I/sI 6.10 (2.0)
Completeness (%) 99.9 (99.8)
Redundancy 3.5 (3.5)
Reﬁnement
Rwork/Rfree 0.2198/0.2626
No. atoms 3,382
Protein 3,259
Ligand/ion 96
Water 27
B-factors 45.90
Protein 44.10
Ligand/ion 110.30
Water 32.60
R.m.s. deviations
Bond lengths (Å) 0.003
Bond angles () 0.77
Ramachandran Statistics
Favoured (%) 92.2
Disallowed (%) 0.0
*Values in parentheses are for highest-resolution shell.
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Figure 2 | Binding comparison of Net4 and Net1 to netrin receptors and laminin. (a) Biolayer interferometry binding kinetic analysis of DCC, neogenin,
and UNC5B to Net4 (red) as well as Net1 (green). AHC sensors were coated with the Fc chimera proteins. Association (from 0 to 300 s) and dissociation
(from 300 to 600 s) phases are shown for 50 nM of both netrins. (b) The SAXS model for the Net4-FL-g1LN-LEa1-4 complex was generated by ﬁrstly
calculating models for Net4-DC-g1LN-LEa1-4 complex (Supplementary Fig. 5d) followed by the addition of the LE and globular domain C. This model
highlights the role of N-terminal globular domains in the interaction. The agreement between experimentally collected SAXS data and model-derived SAXS
data is presented in Supplementary Table 1. (c) Rotary-shadowing electron microscopy image of Net4-DC-g1LN-LEa1-4 clearly showing a 1:1 complex
mediated via the globular domains. (d) Microscale thermophoresis binding analysis of different Net4 mutants to labelled g1LN-LEa1-4. Binding of Net4
lacking the netrin-speciﬁc C domain (Net4-DC). Binding of full-length Net4 (Net4-FL). Analysis of the binding of a Net4 mutant (Net4-DCDKAPGA) in which
the speciﬁc loop b (KAPGA) within LE1 was deleted. Binding of a combined Net4 mutant (Net4-DCE195A,R199A,DKAPGA). Error bars, s.d. (n¼ 3 independent
technical replicates). KD values are shown in the graph (n.b., no binding). (e,f) Laminin-binding epitopes within Net4 (green) compared with the equivalent
positions in Net1 (marine). Note loop b of LE1 of Net4 has an extensive contact area with the LN domain, and the KAPGA motif (shown in stick notation) is
highly ﬂexible. (g) Sequence alignment of Net4, Net1 and netrin-3 showing the laminin-binding region. (h) Solid-phase binding study of Net4 and Net1 to
immobilized laminin g1 (g1LN-LEa1-4). Error bars, s.d. (n¼ 3 independent technical replicates). Scale bar, (c) 100 nm.
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and dimer in solution and that laminin g1 is capable of
destabilizing the Net4-FL dimer. Taken together, our results
establish that full-length Net4 binds to laminin g1 in a 1:1
stoichiometry. In addition, biochemical studies identiﬁed different
epitopes within Net4 responsible for laminin interaction. Our
newly established Net4 laminin-binding mutants can now be used
to determine the speciﬁc role of the Net4-laminin complex in
functional studies because these mutants do not affect cell adhesion
properties of Net4 (Supplementary Fig. 6d) indicating their
exclusive role in laminin binding. Moreover, comparing the
structure of Net4 and Net1 reveals that the laminin-binding
epitopes are not conserved within Net1 (Fig. 2e–g) and indeed
Net1 does not interact with laminin 111 (Fig. 2h).
Net4 disrupts pre-existing laminin networks. Net4 has been
proposed to block laminin polymerization25. However, due to its
nanomolar binding to the laminin g1 chain, we hypothesized that
Net4 not only blocks laminin polymerization but also disrupts
pre-existing laminin network. First, we analysed whether Net4
and the identiﬁed laminin-binding mutant (E195A,R199A),
which still binds in a nanomolar range to the laminin g1 chain,
are able to block laminin polymerization (Fig. 3a and
Supplementary Fig. 7a). Interestingly, Net4-DC as well as the
laminin-binding mutant Net4-DCE195A,R199A blocked laminin
polymerization to the same extent as the N-terminal fragments of
laminin b1 and g1 (Fig. 3b). To address our hypothesis that Net4
is able to disrupt pre-existing laminin networks, we performed
a comprehensive series of different techniques, including
(i) laminin network disruption (Supplementary Fig. 7b),
(ii) size-exclusion chromatography and (iii) atomic force
microscopy of a polymerized Matrigel matrix. Net4 is able to
disrupt pre-existing laminin 111 networks and the ternary node
complex formed by the laminin a1, b1 and g1 chain (Fig. 3c–e).
Moreover, Net4 treatment dramatically weakens the stiffness of the
Matrigel matrix (Fig. 3f). Thus, all approaches clearly highlight that
Net4 is able to disrupt pre-existing laminin networks (Fig. 3c–f).
However, the laminin-binding mutant Net4-DCE195A,R199A is only
able to block laminin polymerization but not to disrupt
pre-existing laminin networks (Fig. 3c,d,f). Our results clearly
demonstrate that N-terminal laminin fragments and Net4, as
proposed previously25,33 as well as the laminin-binding mutant, are
able to block laminin polymerization due to their binding capacity
to the N-terminal laminin domain (LN) (Fig. 3g). These results
establish that Net4 is able to disrupt pre-existing laminin networks
in a non-enzymatic manner, whereas its respective laminin-
binding mutant cannot (Fig. 3g).
Net4 interferes with BM assembly on the cell surface. As Net4
has a high-afﬁnity interaction with laminin g1, a key component
of the BM, we investigated whether Net4 affects BM assembly. As
an in vitro model, we ﬁrst took advantage that BM components
assemble on Schwann cell surfaces only if laminin 111 hetero-
trimers interact via their LN domains34. Therefore, the stable
heterodimeric complex of Net4 with laminin g1 may prevent
efﬁcient BM assembly on Schwann cell surfaces similar to LN
domain truncated laminin 111. Schwann cells were incubated
with laminin 111, collagen IV and nidogen-1, which normally
results in a BM assembly on the cell surface34. Deposition of BM
components was then monitored via immunoﬂuorescence
staining for collagen IV (Col-IV) and laminin (Lmg1) (Fig. 4a).
First, laminin 111 binds to cell surface integrins via its C-terminal
LG domains and assembles via the LN domains of the a1, b1 and
g1 chain. Both interactions are necessary for laminin
deposition34. We observed strong laminin as well as collagen
IV staining when treating cells with only laminin 111, collagen IV
and nidogen-1 (ctrl) (Fig. 4a,b). After addition of wild-type Net4
(Net4-FL) together with BM components, we could neither detect
laminin nor collagen IV deposition by immunoﬂuorescence,
whereas treatment with Net4-FLE195A,R199A showed strong
laminin as well as collagen IV staining as observed in the
control situation (Fig. 4a,b). Moreover, we analysed the inﬂuence
of different molar ratios of laminin 111 to Net4-FL as well as
Net4-FLE195A,R199A (1:0.4, 1:1.8, 1:7 and 1:28). Net4 signiﬁcantly
decreased laminin as well as collagen IV levels on the cell surface
at ratios 1:7 and 1:28, whereas the laminin-binding mutant
(Net4-FLE195A,R199A) had no inﬂuence on laminin and collagen
IV staining intensities (Fig. 4c). In summary, these results
indicate that Net4 can destabilize the polymerization of laminins
containing the laminin g1 chain followed by disassembly of
the BM.
Net4 may affect axon outgrowth through matrix reorganization.
Net4 has been postulated to play similar roles as Net1, mainly due
to their conserved domain features38–40. Furthermore, it has been
proposed that Net4 acts as an outgrowth promoting cue in ex vivo
models such as the olfactory bulb neurite outgrowth3. We
revisited this axon outgrowth function in the light of Net4’s
impact on the extracellular matrix. Olfactory bulb explants from
E15 embryos were cultured in collagen I in the presence of the
N-terminal laminin g1 fragment, Net4-DC, Net4-DC together
with the N-terminal laminin g1 fragment and the laminin-
binding mutant Net4-DCE195A,R199A, which does not interact
with laminin (Fig. 5a). As shown in Fig. 5b, while wild-type Net4
presence is associated with neurite outgrowth, the combination of
Net4 with the N-terminal laminin g1 fragment as well as the
laminin-binding mutant was unable to promote axon outgrowth
(Fig. 5b,c). These data support the view that, unlike Net1, the
axon outgrowth activity of Net4 is not only due to guidance cue
functionality per se. It may additionally be due to Net4 ability to
disrupt the BM surrounding the olfactory bulb through
interactions with laminin-supporting axons to branch through
this physical barrier, even though we cannot exclude other
interpretations. To further analyse this indirect function, we next
focused on the described role of Net4 on angiogenesis.
Net4 affects angiogenesis through matrix reorganization. Most
studies investigating the role of Net4 in angiogenesis in vitro or
ex vivo are using artiﬁcial matrix for the culture in vitro19,20,41–44.
The role of a functional laminin network within artiﬁcial matrix
such as Matrigel for the formation of tube-like structures has so
far not been addressed. A recent study revealed that Net4 inhibits
the formation of endothelial tube-like structure at high
concentrations (1,000 nM) (ref. 20). To conﬁrm this, Human
dermal microvascular endothelial cells (HDMECs) were seeded
on Matrigel and different concentrations (0, 200 and 1,000 nM) of
Net4 (Net4-DC) were added after cell attachment on Matrigel
(Supplementary Fig. 8a). Untreated HDMECs formed cell clusters
connected by honeycomb-like network structures after 14 h.
Upon addition of 200 nM Net4 (Net4-DC), endothelial cells were
able to form networks, whereas treatment with 1,000 nM Net4
completely abolished tube-like structure formation (Fig. 6a and
Supplementary Fig. 8a,b). In addition, HDMEC tube-like
structure formation was monitored for 14 h (Supplementary
Movies 2 and 3); upon Net4 treatment (1,000 nM) cell
morphology was dramatically changed and no network was
established. Instead, cells moved together and formed
pronounced aggregates within 5 h and remained clustered over
the 14 h period (Supplementary Fig. 8c). On the basis of our
hypothesis that Net4 disrupts laminin-laminin complexes, we
further investigated whether Net4 alters tube-like structure
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formation in a cell-type independent manner. Upon Net4
treatment, tube-like structure formation in microvascular
(HDMEC), macrovascular (HUVEC) and lymphatic (HDLEC)
endothelial cell lines was inhibited compared with control
(Supplementary Fig. 8d). In addition, Net4 also destabilizes an
already established vessel-like network on Matrigel 7 h post
treatment followed by increased cell aggregation after 14 h
(Supplementary Fig. 8e). In a subsequent step, we further
determined whether the exchange of the LN-LEa1 domains
within the laminin g1 chain fragment with the respective
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laminin-binding domains of Net4 LN-LE1 might lead to gain of
function. Both chimeric fragments (chimera 2: Net4LN-LE1-
2—g1LEa3-4 and chimera 3: Net4LN-LE1—g1LEa2-4) inhibited
endothelial tube-like structure formation in the same way as
Net4-DC, whereas the chimeric fragment (chimera 1: g1LN-
LEa1—Net4LE2-31/2) did not show any alteration of endothelial
tube-like networks at the concentrations tested (Supplementary
Fig. 8f).
To determine whether alterations in the laminin network are the
trigger of Net4 mediated inhibition of tube-like structures, we
performed the Matrigel assay with the structure-guided Net4
laminin-binding mutants (Net4-DCE195A, Net4-DCR199A, and
Net4-DCDKAPGA and Net4-DCE195A,R199A). HDMECs treated
with these laminin g1 binding mutants established cell clusters
with ﬁlamentous interconnections in the same manner as
untreated and laminin g1LN-LEa1-4 fragment treated endothelial
cells (Fig. 6a, left; Supplementary Fig. 9a,b). Net4 signiﬁcantly
decreased cell cluster interconnections (tube number), whereas
tube numbers in g1LN-LEa1-4- and Net4 laminin-binding
mutants-treated endothelial cells were equal to untreated endothe-
lial cells (Fig. 6a, right; Supplementary Fig. 9a,b). The inhibition of
tube-like structure formation through Net4 was rescued via pre-
incubation of Net4 together with the laminin-binding domain of
the laminin g1 chain (g1LN-LEa1-4). Analysis of endothelial tube
numbers showed no difference between untreated, treatment with
g1LN-LEa1-4, and combined treatment of g1LN-LEa1-4 together
with Net4 (Fig. 6b and Supplementary Fig. 9a,b). This ﬁnding
demonstrates that the laminin g1 fragment competes with the
interaction of Net4 to the laminin g1 chain of the laminin 111
heterotrimer. To conﬁrm the cell-independent activity of Net4, we
also investigated the inﬂuence of Net4 on the tube-like structures45
made by the mouse melanoma B16-F1 cell line. Here, Net4
could also block the formation of tube-like structures in a
laminin-binding-dependent manner (Supplementary Fig. 10a,b).
Furthermore, we analyzed the effect of netrin-4 on endothelial cells
in a laminin-free matrix is in agreement with the presented model:
addition of netrin-4 had no effect on endothelial cell sprouting in a
collagen I matrix (Fig. 6c). To exclude that the observed activity of
Net4 is only mediated when Net4 is deposited within the laminin
network of the Matrigel matrix, we designed a Net4 protein fused
to the N-terminal agrin domain (Agrin-Net4-DC). First, we tested
the binding activity of Agrin-Net4-DC to the laminin g1LN-LEa1-
4 fragment. This construct binds with the same afﬁnity to the
laminin g1LN-LEa1-4 fragment as wild-type Net4 (Supplementary
Fig. 6c). Moreover, we tested the binding activity of the N-terminal
agrin domain to laminin 111. Here, we took advantage of a
previously generated laminin 111 construct lacking the N-terminal
domains (LN-LEa1-4) of the laminin g1 chain (Lm111Dg1LN-
LEa1-4)34. As expected, Net4 does not bind to Lm111Dg1LN-
LEa1-4 (Supplementary Fig. 11a), whereas Agrin-Net4-DC and the
laminin-binding mutant fused to the N-terminal agrin domain
(Agrin-Net4-DCE195A,R199A) interact in the nanomolar range with
Lm111Dg1LN-LEa1-4 (Supplementary Fig. 11b). Treatment of
HDMECs with Agrin-Net4-DC abolished tube-like structures to
the same extend as wild-type Net4 (Net4-DC and Net4-FL,
Supplementary Figs 9a and 11c). However, the laminin-binding
mutant fused to the N-terminal agrin domain as well as the
combination of Agrin-Net4-DC together with the laminin g1LN-
LEa1-4 fragment signiﬁcantly blocked the activity of Net4
(Supplementary Fig. 11c). Thus, our data support the view that a
formed laminin network within the Matrigel matrix is essential to
generate tube-like structures and that the reported inhibitory
activity of Net4 is mediated through binding to the LN domain of
the laminin g1 chain and disruption of the BM.
To unravel the physiological signiﬁcance of our ﬁndings we
performed a more physiological relevant angiogenesis assay,
where endothelial cells were co-cultured with pericytes to form
tubes within a laminin-free collagen I matrix28. Here, endothelial
cells and pericytes form a continuous BM formed by laminin
511 and collagen IV. Treatment of the co-culture with Net4
completely abolished tube formation, whereas the laminin-
binding mutant showed no effect (Fig. 6d). Staining of
endothelial tubes highlight that laminin as well as collagen IV
is not present along the tubes in the Net4 treated set up (Fig. 6e).
These results not only suggest that Net4 disrupts the laminin
network resulting in the decline of endothelial tubes but also
emphasize that the laminin network is the key component of the
vBM essential for vessel formation.
The Net4/laminin interaction destabilizes capillaries in vivo.
To determine how Net4 affects capillary networks an ex ovo
chicken Chick Chorioallantoic Membrane (CAM) angiogenesis
assay46 was performed. Established capillary networks were
treated with full-length Net4 (Net4-FL) and the laminin-
binding mutant (Net4-FLE195A,R199A); blood and micro-
capillaries were visualized using FITC-dextran injection 48 h
post treatment. In the untreated (ctrl) CAMs, a micro-vascular
network appeared 48 h post treatment. Upon addition of Net4,
the capillary network dramatically changed as the observed
vascularized area was signiﬁcantly decreased (Fig. 7a). Treating
the CAMs with the laminin-binding mutant Net4-FLE195A,R199A
had no signiﬁcant effect. Histological staining (haematoxylin,
eosin; H&E) of CAMs to detect the capillary density of untreated
Figure 3 | Net4 disrupts pre-existing laminin networks. (a) Inhibition of laminin 111 polymerization (Lm111) by human laminin b1 (b1LN-LEa1-4), mouse
laminin g1 (g1LN-LEa1-4), mouse Net1 (Net1-DC), mouse Net4-DC and the laminin-binding mutant mouse Net4-DCE195A,R199A. For the experimental
scheme depicting the laminin 111 polymerization assay see Supplementary Fig. 7a. SDS–PAGE analysis of the pellet (P) and the supernatant fraction (S). The
position of the laminin chains (arrow heads) and the recombinant proteins (stars) are indicated. (b) Densitometric analysis of three independent
polymerization experiments and the percentage of the pellet fraction are displayed. (mean±s.d.; n¼ 3; ****Po0.00006 (ctrl vs b1LN-LEa1-4, Net4-DC and
Net4-DCE195A,R199A) and ***P¼0.0004 (ctrl vs g1LN-LEa1-4); ns, not signiﬁcant). (c) For the method procedure see Supplementary Fig. 7b. The resulting
fractions (supernatant of laminin polymerization (S), supernatant after addition of different proteins (Sþ ) and polymer (Pþ )) were separated by
SDS–PAGE, followed by Coomassie Brilliant-Blue staining. Different laminin chains are colour labelled (a1 (yellow), b1 (green) and g1 (blue)) and added
recombinant proteins are indicated with asterisks. (d) The ratio between polymer (Pþ ) and supernatant (Sþ ) was determined by densitometric analysis
of at least three independent experiments (mean±s.d.; n¼ 3; ****P¼0.00005). (e) N-terminal laminin fragments (LN-LEa1-4) of a1 (yellow), b1 (green)
and g1 (blue) as well as MBP-Net4-DC (red) single proteins were analysed using analytical size-exclusion chromatography (top). SEC proﬁle of the laminin
fragment g1LN-LEa1-4 (g1) in complex with MBP-Net4-DC (green, middle). Complexes [a1-b1-g1 (blue) and a1-b1-g1þMBP-Net4-DC (red)] were analysed
by SEC (bottom) revealing that the MBP-Net4-DC is able to disrupt the a1-b1-g1 complex. Asterisks indicate the single proteins within the complex.
(f) Atomic force microscopy anaylsis of a polymerized Matrigel matrix treated with Net4-DC or with the laminin-binding mutant Net4-DCE195A,R199A.
(g) Model depicting inhibition of laminin polymerization via laminin b1 (b1LN-LEa1-4), laminin g1 (g1LN-LEa1-4), mouse Net4-DC, and the laminin-binding
mutant mouse Net4-DCE195A,R199A but not via mouse Net1 (Net1-DC). The pre-existing laminin network can only be solubilized through Net4. Error bars,
s.d. (n¼ 3 independent technical replicates).
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and Net4-FLE195A,R199A-treated CAMs displayed a dense
capillary lining, whereas Net4-treated CAMs revealed fewer and
more rounded capillaries (Fig. 7b).
One of the key pathophysiological roles of Net4 associated with
its angiogenic activity is its inhibiting effect on tumour
progression. Subcutaneously injected cancer cells overexpressing
Net4 in mice establish tumours with fewer vessels than tumours
established by untransfected cells18,19. Therefore, we investigated
whether the tumour-suppressive activity of Net4 is mediated
through binding to laminin. HCMel12 mouse melanoma cells
were injected in mice and, upon macroscopic detection; tumour
growth was monitored and daily injection of either a control
protein (mouse serum albumin), Net4 or its laminin-binding
mutant was administered (Fig. 7c). The size of tumours treated
with Net4 was reduced by 50% of the size in comparison to the
control-treated animals. Moreover, our data establish that the
interaction of Net4 with laminin is essential for its tumour-
suppressive activity as the Net4 mutant (Net4-FLE195A,R199A),
affected in laminin binding, had no impact on tumour growth
(Fig. 7d,e).
We thus moved back to the ex ovo CAM model to further
dissect the impact of Net4 on capillaries. We investigated in
CAMs treated with Net4 or its laminin-binding mutant, the
branching pattern that is highly altered only in the Net4-treated
CAM. To highlight the capillary branching hierarchy, the vessel
diameters were presented in a radial graph. This analysis clearly
indicates that diameters of vessels within Net4-FLE195A,R199A-
treated CAMs span the full range of diameters found in an
established vessel hierarchy. In contrast, vessels in Net4-FL-
treated CAMs showed an altered distribution of diameters as
large vessels exhibited smaller diameters and small capillaries
were not present (Fig. 8a, left). Net4-FLE195A,R199A-treated CAMs
display a distinct established hierarchy pattern, starting with large
vessels (1., 45–60mm diameter) from which smaller capillaries
branch with decreasing diameter (2., 30–45 mm; 3., 15–30 mm; and
4., 3–6 mm). The altered vessel hierarchy in Net4-treated CAMs is
clearly demonstrated by decreased diameters as large vessels
(1., 28–37 mm) as well as small capillaries (2., 10–20mm and 3.,
7–10 mm) exhibit reduced calibers (Fig. 8a, right). Thus, the
laminin–laminin interaction is required to maintain proper
capillary networks in vivo.
As Net4 appears to disconnect the laminin network ex ovo, we
hypothesized that the disruption of the laminin network may
affect the whole vBM thereby inﬂuencing the interaction of
pericytes with the endothelium. Therefore, endothelial and
perivascular cell distribution was studied in CAMs treated
with the laminin-binding mutant (Net4-FLE195A,R199A) or Net4.
Ultrastructural analyses of Net4-FLE195A,R199A-treated CAMs
suggested that endothelial cells are closely surrounded by
pericytes, whereas Net4 treatment leads to detachment of
pericytes from the endothelium with altered pericyte morphology
(Fig. 8b, top). Embedding of pericytes into the vBM stabilizes
newly-formed vessels. Net4-FLE195A,R199A-treated CAMs exhib-
ited a continuous vBM along the endothelium and surrounding
pericytes. Upon Net4 treatment, the vBM almost disappeared on
endothelial cell surfaces as well as along pericytes (Fig. 8b, middle
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and bottom). These results indicate that Net4 dissociates laminin
heterotrimers from the vBM and disturbs the endothelial/
perivascular cell interaction in vivo.
Discussion
Far from its expected role as a guidance cue, a combination of
structural, in vitro and in vivo experiments demonstrate that Net4
behaves in a completely different manner than its well-studied
family member Net1. Our data demonstrate that Net4 not only
strongly binds to laminin g1 -thereby blocks efﬁciently laminin
polymerization- but also actively disrupts pre-existing laminin
networks in a non-enzymatic manner. Net4 is clearly a unique
member among the netrin family, showing non-enzymatic
disruptive forces towards matured BMs.
It has been reported that Net4 demonstrates axonal growth
activity3 and anti-angiogenic activity in vitro by inhibiting
endothelial tube-like structure formation18–20. Furthermore,
Net4 overexpression in different cancer cells reveals a decreased
vascularization in vivo18,19. Even though we cannot discard that
Net4 is having an alternative function via unknown receptor, we
propose here that the basis of the effects reported on axonal
growth, angiogenesis and tumour progression is due to disruption
of pre-existing laminin networks resulting in the disruption of the
entire BM. Endothelial assemblies need to form a continuous
vBM together with pericytes28. Our treatment studies with Net4
conﬁrm this fact due to the fact that the disruption of the vBM
results in the decline of endothelial tubes. In terms of the effect of
Net4 on neurite outgrowth in the olfactory bulb assay the role of
the BM is different. Here, axons need to branch through the BM
as a physical barrier and the disruption of this barrier through
Net4 supports axonal outgrowth. Interestingly, most of the
cellular effects reported on Net4 have been performed using an
artiﬁcial matrix such as Matrigel that contains mainly laminin
111 (refs 19,20,47,48). As the LN domain of the g1 chain is the
major binding partner of Net4, we hypothesized that it affects the
laminin network within the Matrigel matrix instead of directly
affecting cell-signalling pathways. Similarly inhibition of blood
vessel formation by Net4 is believed to be triggered through
binding to the Net1 receptors DCC (DCC, neogenin) and UNC5
(UNC5A-D)18,19. However, we could not detect direct inter-
actions of Net4 with any of these receptors. Comparison of the
high-resolution structures of Net1 (refs 22–24) and Net4 explains
in detail this absence of interaction (Fig. 1e–h and Supplementary
Fig. 1a).
Structure based mutations of Net4 in combination with in vivo
and ex vivo assays allowed assignment of Net4 functionality to its
laminin-binding capability rather than Net4’s interaction with
Net1 receptors. Thus, our hypothesis is that Net4 is not a classic
ligand activating a membrane receptor with a downstream
signalling but rather a regulator of basal membrane maintenance,
which indirectly impacts key functions such as axonal growth and
angiogenesis. Our study rather support the view that Net4 is a
unique protein able to disrupt laminin g1 containing BMs and
this can turn as an useful tool be used to investigate the pivotal
role of laminin–laminin interactions in biological processes, for
example, muscle formation, somitogenesis and neural tube
formation.
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In the vasculature, laminin disassembly destabilizes three-
dimensional endothelial tubes in an endothelial/pericyte-like cell
co-culture via interfering with the formation of a continuous BM
along endothelial cell surfaces. Vessel maturation is affected by
establishing a continuous BM along endothelial tube-linings.
Cooperation between endothelial (ECs) and PVCs induces the
production of pivotal matrix components such as nidogen-1,
linking the collagen IV structure to the laminin network, and the
a5-chain shaping laminin 511, which is the predominant laminin
heterotrimer in mature capillaries28. The ﬁnding that treatment of
an EC/PVC co-culture and chicken CAMs with Net4 results in
decreased vascularized areas further highlights the essential role
of vascular laminin networks in angiogenic processes.
Furthermore, the Net4 laminin-binding mutant showed no
effect on angiogenesis. Remarkably, Net4 disrupts the entire
vBM lying between the endothelium and pericytes as well as the
BM surrounding pericytes inhibiting stabilization of the capillary
network and formation of the common vessel hierarchy ex ovo.
Mural cells embedded in the vBM are deﬁned as pericytes29.
Upon their loss, as demonstrated by ultrastructure analyses of
Net4-treated CAMs, the phenotype of pericytes is altered to a
more mural cell character. These ﬁndings are of potential
importance in modulation of cancer progression where blood
vessels are not always well organized, but appear destabilized and
are often leaky, which hampers drug delivery and increases
tumour cell spread49–51. The complex between laminin g1 and
Net4 clearly hinders the formation of, or even disrupts, the
laminin network. Interestingly, disruption of the vBM leads to
detachment of pericytes from the endothelium resulting in the
collapse of the entire capillary network (model pictured in
Fig. 8c), which may also help to reduce tumour progression. A
recent study showed increased permeability in lymphatic vessels
upon Net4 overexpression21, which ﬁts with the proposed model.
Of interest, this model supports the view that the impact of Net4
depends highly on its ability to ‘titrate’ laminin and thus an
important aspect that remains to be investigated further in animal
models is how physiological levels of Net4 actually modulates
basal membranes and how in pathological conditions, up- or
downregulation of Net4 directly affects the BM and thus the cell
behaviour in this Net4 high/low environment. Several studies
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have shown that Net4 expression is modulated in cancer and as
an example is inversely associated with cancer progression52
suggesting that Net4 could represent an important modulator of
tumoral matrix and thus a putative therapeutic target. Finally, our
study not only highlight the key role of laminin networks within
the vBM but also shows that Net4 disrupts pre-existing laminin
networks and BMs in a non-enzymatic manner.
Methods
Recombinant protein expression and puriﬁcation. Net4-FL, g1LN-LEa1-4 and
serum albumin from Mus musculus, (Net4: NP_067295, aa: 20-628, g1LN-LEa1-4:
NP_034813, aa: 34-492, serum albumin: NP_033784, aa: 1-608) and a1LN-LEa1-4,
b1LN-LEa1-4 from Homo sapiens (a1LN-LEa1-4: NP_005550, aa: 18-453, b1LN-
LEa1-4: NP_002282, aa: 31-509) were cloned into a modiﬁed pCEP vector with an
N-terminal double Strep II-tag. Net4-DC from Mus musculus (NP_067295, aa:
20-462) was cloned into a modiﬁed pCEP vector with an N-terminal octa-histidine
(His8) tag or with an N-terminal double Strep II-tag. HEK293 cells were stably
transfected followed by screening for subclones with a high level of protein
expression. Net4-DC, Net4-FL, g1LN-LEa1-4, a1LN-LEa1-4, and b1LN-LEa1-4
were puriﬁed by streptactin-sepharose (IBA) and Net4-DC by metal-afﬁnity
chromatography using nickel TALON beads (Clontech) followed by the removal of
the double Strep II-tag and His8-tag by thrombin digestion. The puriﬁed proteins
were then dialyzed against 1 x PBS. Afﬁnity puriﬁed proteins were further pro-
cessed by size-exclusion chromatography (SEC) in TBS buffer (50mM Tris-HCl,
pH 7.5; 200mM NaCl) on a Superdex 200 column using the A¨KTA FPLC system
(GE Healthcare Life Sciences USA) equipped with UV absorbance detector and
UNICORN v5.11 software as previously described. The complex of Net4-FL-g1LN-
LEa1-4 and Net4-DC-g1LN-LEa1-4 was puriﬁed using SEC by mixing the peak
fractions for individual species. Protein concentrations were measured using
extinction coefﬁcient and molecular weight values derived from the ProtParam
utility53 available on the ExPaSy server54.
Design of chimeric constructs and site-directed mutagenesis. To design Net4
containing LNg1 binding domains we generated chimeric molecules by overlap
PCR using the Q5 (New England Biolabs) polymerase. The domains from Net4
(Net4: NP_067295) were replaced by the corresponding laminin g1 sequences
(laminin g1: NP_034813). The following constructs were ampliﬁed, cloned (with
an N-terminal double Strep 2-tag), veriﬁed by sequencing, expressed and puriﬁed:
Net4LN-LE1-2—g1LEa3-4 (Net4 aa: 20-394 fused to laminin g1 aa: 396-492),
Net4LN-LE1—g1LEa2-4 (Net4 aa: 20-331 fused to laminin g1 aa: 340-492), g1LN-
LEa1—Net4LE2-31/2 (Laminin g1 aa: 44-339 fused to Net4 aa: 332-462) and Net4-
DC—N-term agrin (NP_067295, aa: 20-462, E195A, R199A, fused to NP_067617,
aa: 33–164). Furthermore, the following mutated Net4 molecules were generated:
Net4-FL: (NP_067295, aa: 20-628, E195A,R199A), Net4-DCE195A,R199A,DKAPGA:
(NP_067295, aa: 20-462, E195A, R199A and D281KAPGA285), Net4-
DCE195A,R199A: (NP_067295, aa: 20-462, E195A, R199A and D281KAPGA285),
and Net4-DCE195A,R199A—N-term agrin (NP_067295, aa: 20-462, E195A, R199A,
fused to NP_067617, aa: 33–164). All produced proteins are shown in
Supplementary Fig. 12.
Structure determination of Net4. Net4-DC was applied to a Superdex 200 SEC
column (GE Healthcare) equilibrated with 50mMTris/Tris-HCl, pH 7.5, 0.2M
NaCl at room temperature and the collected peak fractions were immediately
concentrated to 1.2mgml 1 and used for crystallization. Net4-DC crystals were
grown by hanging-drop vapour diffusion at 293 K by mixing 2 ml of protein
solution, 1.6 ml of reservoir solution (20% PEG3350, 0.2M calcium acetate, and
0.1M sodium cacodylate pH 6.5), and 0.4 ml of 1M NDSB-256 from the Hampton
HR2-428 additive screen (Hampton Research). Crystals appeared after 1 week and
were soaked in mother liquor containing 10% ethylene glycol for 5–10min before
ﬂash freezing in liquid nitrogen. Diffraction data was collected on a Rigaku MM-
007HF (l¼ 1.54178 Å) at 100 K. The data set was indexed, integrated and scaled
with the HKL2000 suite. The phases were determined by molecular replacement
using a polyserine laminin-b homology model (PDB4AQS55) from Swissmodel in
Phaser56. The model was built and reﬁned using Coot57, the Phenix Reﬁne and
Autobuild programs58 and Refmac59,60.
Octet-binding studies. Binding of Net4 or Net1 to DCC, neogenin, and UNC5H2
was analysed by biolayer interferometry using the Octet RED96 system (Pall
ForteBio). Recombinant human DCC/Fc, mouse neogenin/Fc and rat UNC5H2/Fc
chimera were obtained from Bio-Techne. Proteins were stored frozen and diluted
into binding buffer (PBS, 0.1% BSA, 0.02% Tween 20). Binding assays were per-
formed in 96-well microtitre plates at 30 C with orbital sensor agitation at
1,000 r.p.m. Fc chimera proteins (2 mgml 1) were loaded onto anti-human Fc
(AHC) biosensors for 10min. Biosensors were washed with binding buffer for 60 s
and placed in wells containing the various netrins (50 nM in binding buffer).
Association was observed for 10min, then biosensors are incubated in binding
buffer for additional 10min to observe dissociation of the complex. Uncoated
biosensors were run in parallel for non-speciﬁc binding. Binding curves were
analysed by Octet User software (ForteBio). Three independent technical replicates
were performed.
Microscale thermophoresis binding assay. Binding of the labelled Laminin g1
short arm fragment (g1LN-LEa1-4) to Net4 variants and its respective mutants
were measured using microscale thermophoresis. A range of concentrations of the
required ligands (from 0.08 to 1,000 nM for Net4 and from 0.45 to 4,000 nM for
Net4 mutants) were incubated with 2 nM of g1LN-LEa1-4 in the assay buffer
(50mM Tris/HCl, pH 7.4, 150mM NaCl, 2mM CaCl2 supplemented with 3%
BSA) for 10min. Samples were loaded into NanoTemper glass capillaries and
microscale thermophoresis was carried out using 10% light-emitting diode power
and 80% MST power on a NanoTemper monolith NT.115 (ref. 61). KD values were
calculated from independent technical triplicate experiments using the mass action
equation via the NanoTemper software.
Laminin network disruption assay. The laminin polymerization-blocking assay
was performed as described in the Supplementary Fig. 9b and the laminin polymer
disruption assay setup is described in the Supplementary Fig. 9c. Mouse laminin
111 (Sigma-Aldrich, Germany) was diluted to 0.35 mM in 50mM Tis-HCl, pH 7.4;
150mM NaCl; 0.1% Triton-X100; 1mM CaCl2 and incubated at 37 C for 3 h to
polymerize. Afterwards, polymerized laminin was centrifuged (10,000g; 15min) to
separate formed laminin polymer from non-polymeric laminin. Different proteins
(Net4-DC, Net4-DCE195A,R199A) were added at a concentration of 2.1 mM respec-
tively to the laminin polymer at 37 C for additional 3 h. Samples were centrifuged
and all three fractions (supernatant (S), supernatantþ (Sþ ), pelletþ (Pþ );
Supplementary Fig. 7b) were analysed by SDS–PAGE (SDS–polyacrylamide gel
electrophoresis) followed by fast Coomassie Blue staining (Thermo Scientiﬁc,
Germany). Band intensities were determined using the ImageJ software and ratios
between the polymer fraction (Pþ ) and supernatant (Sþ ) are displayed.
Laminin assembly on Schwann cell surface. Rat Schwann cells were cultured in
Dulbecco’s Eagle medium, 10% fetal calf serum (Atlanta Biological), neuregulin
(0.5 mgml 1, Sigma), forskalin (0.2 mgml 1, Sigma) and penicillin-streptomycin.
Cells at passage 22-29 were seeded onto 24-well dishes (Sigma) and incubated with
collagen IV, nidogen-1 and different laminin constructs. Additionally, cells were
treated with 28-fold excess compared with laminin of Net4-FL, Net4-FLE195A,R199A
at 37oC for 1 h. Schwann cells were rinsed with PBS and ﬁxed in 3% paraf-
ormaldehyde for 20min followed by blocking with 5% goat serum in PBS overnight
at 4 C. Cells were incubated with anti-laminin g1 (1:200, Millipore, MAB1920)
and anti-collagen IV (10mgml 1, Millipore, AB756P) at room temperature for 1 h.
Alexa Fluor 647 goat anti-mouse and Alexa Fluor 488 goat anti-rabbit secondary
antibodies (Molecular Probes) were used at 1:100 and counterstained with
40,6-diamindino-2-phenylindol. Digital images of protein immunoﬂuorescene
levels were recorded with IPLAB 3.5 software (Scanalytics) and quantiﬁed with
IMAGE J. Validation information for commercial antibodies is available on the
manufacturers’ websites. All experiments were performed in groups of ﬁve inde-
pendent cultures and repeated at least twice.
Neurite outgrowth assay. Olfactory bulb (OB) explants were isolated from rat
embryos E15 (n¼ 19 Embryos at E15 were collect from pregnant Sprague Dawley
female rat). OB explants were embedded in Collagen I isolated from rat tail and
cultured with 28 nM of Net4-FL or Net4-FLE195A,R199A for 24 h. Explants were
then ﬁxed in 4% PFA at room temperature for 1 h and permeabilized with PBST
(PBS, 0.1% Triton-X100) for 10min. Next, explants were blocked with PBST, 1%
normal donkey serum (Jackson Immunoresearch) at room temperature for 2 h and
incubated with mouse polyclonal Tuj1 antibody, 1/500 (Babco, MMS435P) diluted
in PBST at 4 C overnight. After 3 times washing with PBST, explants were
incubated with Alexa488 donkey anti mouse (1/500; Life Technologies, A21202) at
room temperature for 1 h, followed by 3 washes in PBST and mount with mowiol.
Explants were imaged with Axiovert200M, Zeiss. Neurite and explant area were
analysed with FIJI in order to determine neurite density (neurite area/explant area).
Validation information for commercial antibodies is available on the manu-
facturers’ websites. All experiments were performed in groups of ﬁve independent
cultures and repeated at least twice.
Cell culture. HEK293 EBNA cells as well as the mouse melanoma B16-F1
cell line were obtained from ATCC. HDMEC and HDLEC were obtained from
Promocell; HUVEC from Lonza. The endothelial cells were cultured in Vasculife
VEGF-Mv Medium Complete Kit (Cell Systems) according to the manufacturer´s
instructions. The mouse melanoma cell line (HCMel12) was kindly provided by
T. Tu¨ting (University of Magdeburg)62. The mouse melanoma cell lines HCMel12
and B16-F1 as well as HEK293 EBNA cells were cultured in Dulbecco´s Modiﬁed
Eagle Medium (Gibco) supplemented with 10% fetal bovine serum. PVCs
were isolated from meninigi of the Anxa5-LacZ reporter mouse strain63.
PVCs were cultured in DMEM supplemented with 10% FCS and used at
passages 28–40.
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Tube-like formation assay. Cells were seeded at a density of 25,000 cells per well
onto chamber slides (Labtek) or ibidi slides (ibidi) previously coated at 37 C with
Matrigel BM matrix (Corning, New York, USA) for 30min to allow polymeriza-
tion. For the tube formation assay, the indicated proteins were added directly after
seeding the cells. Cells were incubated for 14 h. For the tube regression assay
proteins were added 7 h after seeding the endothelial cells, which had established a
tubular network. Recombinant proteins were added at the concentrations indicated
and in terms of endothelial cells treatment PDGF as well as VEGF (Biomol) was
added at ﬁnal concentrations of 10 ngml 1. Tube formation was documented by
bright-ﬁeld microscopy using a Nikon Eclipse TE2000-U microscope. In order to
investigate the time course of tube formation, we performed time-lapse microscopy
using an Olympus IX81. All experiments were performed in groups of ﬁve inde-
pendent cultures and repeated at least three times.
Three-dimensional culture in collagen I matrix. Endothelial and pericyte-like
cells (HUVECs/PVCs) were co-cultured in 2% collagen I gel. Cultures were incu-
bated in ECGM2 medium supplemented with PDGF-BB and VEGF (10 ngml 1
each) for 6 days. Recombinant Net4-FL and Net4-FLE195A,R199A were added to the
three-dimensional gel solution at indicated concentration. Medium (supplemented
with PDGF-BB, VEGF, and Net4-FL or Net4-FLE195A,R199A) was replaced every
48 h. Samples were ﬁxed with Dent’s ﬁxative and immunostained for collagen IV
(1:500; AB769, Chemicon), laminin g1 (1:500; kind gift from U. Mayer, University
of East Anglia), and human CD31 (1:500; 555444, BD Biosciences). DNA was
stained by Hoechst 33258. Overview pictures were taken from each sample by
using a Zeiss Axioplan microscope and average tube length was calculated by the
Volocity software. Optical section images were taken by a Zeiss Apotome micro-
scope and processed by Axiovision program. All experiments were performed in
groups of ﬁve independent cultures and repeated at least three times. Validation
information for the laminin g1 antibody is presented in the work of Mayer et al.64
Chick chorioallantoic membrane angiogenesis assay. The ex ovo culture of the
chicken embryos was adapted from Auerbach et al.46 Brieﬂy, fertilized Ross
chicken eggs (Wu¨thrich Bru¨terei AG, Switzerland) were incubated at 37 C for 3
days in humidiﬁed atmosphere. On day 3, the eggs were carefully opened and their
content was transferred into 100 20mm Petri dishes (Corning, Switzerland). The
chicken embryos were incubated in the same conditions for 6 more days. On day 9,
the polyethylene glycol (PEG) hydrogels containing no protein and different
proteins (Net4-FL, Net4-FLE195A,R199A) were placed on the surface of the CAM.
15ml PEG hydrogels were formed by Factor XIIIa-catalysed crosslinking of two
eight-arm PEG components (8-PEG–Gln and 8-PEG–MMPsensitive–Lys) in 50mM
Tris pH 7.6, 50mM CaCl2 buffer to a ﬁnal PEG concentration of 2% (w/v). Each
hydrogel contained 4.25 mg of recombinant Net4-FL, or Net4-FLE195A,R199A, which
were added to the hydrogel mixture before polymerization. After 48 h of treatment,
100ml of 2.5% FITC-dextran (MW 20,000, Sigma-Aldrich, Switzerland) in 0.9%
NaCl solution were injected intravenously in the CAM. The vasculature was
visualized by ﬂuorescence microscopy and images around the treatment site were
collected. All experiments were performed in groups of ﬁve independent cultures
and repeated at least twice.
The images collected by ﬂuorescence microscopy were analysed using the
ImageJ software (ImageJ 1.48, http://imagej.nih.gov/) using a script based on the
quantiﬁcation method developed by Blacher et al.65 Background of each image was
evened out and the contrast was enhanced. Then the threshold was adjusted
manually do discriminate the vascularized area from the non-vascularized area,
and the image was transformed into a binary image. A series of ﬁlters were applied
then to reﬁne the capillary structures. Region of interests (ROIs) were set manually
to exclude second-order and higher-ranking blood vessels and regions with
underlying blood vessels. The vascularized areas within the ROIs, as well as the
total ROI area, were measured. The obtained values were used to determine the
distribution vascularized areas in the capillary network. All experiments were
performed in groups of ﬁve independent cultures and repeated at least three times.
Immunohistochemistry of the CAM. After live imaging, the CAMs were ﬁxed
with 4% para-formaldehyde solution by applying the solution both on top and
beneath the CAM membranes and incubated at room temperature for 1 h. The area
around the treatment site was carefully cut out and placed between cellulose sheets
before being processed for parafﬁn embedding. Tissue sections of 4 mm were cut
with a microtome and mounted on glass slides for haematoxylin and eosin staining.
Transmission electron microscopy analyses of CAM capillaries. After live
imaging, CAMs were ﬁxed with 2.5% glutaraldehyde (buffered with 0.1M sodium-
cacodylate, pH 7.4, 540mOsm.) by applying the solution both on top and beneath
the CAM membranes. They were post-ﬁxed in 1% OsO4 (0.1M sodium-cacodylate,
pH 7.4, 340mOsm), dehydrated in ethanol and embedded in Epon 812 (Fluka,
Buchs, Switzerland). Semi-thin sections were prepared, stained with toluidine blue,
and analysed with a light microscope66,67. Representative areas were selected and
further imaged by transmission electron microscopy. Tissue samples from groups
of three of three independent biological replicates were analysed.
Mice model of melanoma. The melanoma HCmel12 cell line, which sponta-
neously develops lung metastases after intracutaneous injection in immuno-
competent C57BL/6 mice, was established from a primary Hgf-Cdk4R24C
melanoma62. For tumour transplantation 2 105 cells in 100 ml 1PBS were
injected intracutaneously into the ﬂanks of C57BL/6 mice (female, n¼ 5, 8 weeks of
age) and tumour development was monitored by visual inspection and palpation.
When tumours exceed 2mm groups of ﬁve mice were peritumorally injected daily
with 1 mM of mouse albumin (ctrl), Net4-DC, Net4-FL and Net4-FLE195A,R199A for
10 consecutive days. Tumour sizes were measured every second day and recorded
as mean diameter in mm. Mice with tumours exceeding 20mm diameter were
killed. All experiments were performed in groups of ﬁve mice and repeated
independently at least twice.
Statistics. Statistical analysis was performed using the GraphPad Prism software
(GraphPad Prism 5.00). The two sided t-test was used for statistical analysis,
statistical analyses of the Schwann cell assay was performed using the one-way
analysis of variance followed by a pairwise comparison using the Holm–Sidak
method. Results are displayed as mean±s.d. except the one of the neurite out-
growth assay, in which the results are displayed as±s.e.m.
Study approval. All animal experiments were performed in accordance with the
German laws for animal protection and were approved by the State Ofﬁce North
Rhine-Westphalia (LANUV), Germany or by the CECCAP, France.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding authors upon request. Coordinates and structure factors
for Net-4DC have been deposited in Protein Data Bank under accession code
4WNX.
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